Skip to search formSkip to main contentSkip to account menu

nepafenac 1 MG/ML Ophthalmic Suspension [Nevanac]

Known as: NEPAFENAC 1 mg in 1 mL OPHTHALMIC SUSPENSION/ DROPS [NEVANAC], Nevanac 1 MG/ML Ophthalmic Suspension, NEPAFENAC 1 mg in 1 mL OPHTHALMIC SUSPENSION [Nevanac] 
National Institutes of Health

Related topics

Related topics

13 relations
Benzalkonium ChlorideCarbomer-974PEdetic Acid, Disodium SaltHydrochloric Acid

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
In Vitro and Ex Vivo Evaluation of Nepafenac-Based Cyclodextrin Microparticles for Treatment of Eye Inflammation
The aim of this study was to design and evaluate novel cyclodextrin (CD)-based aggregate formulations to efficiently deliver… 
2018
2018
Improved Ocular Delivery of Nepafenac by Cyclodextrin Complexation
Nepafenac is a nonsteroidal anti-inflammatory drug (NSAID), currently only available as 0.1% ophthalmic suspension (Nevanac… 
2006
2006
To Market, To Market – 2005
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)